Cholera Vaccine, Live, Oral (Vaxchora)
Cholera Vaccine, Live, Oral is an FDA-licensed reference biologic from Bavarian Nordic A/S. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2020
Reference approved
Reference product
Vaxchora Cholera Vaccine, Live, Oral
Bavarian Nordic A/S
- Approved
- Dec 23, 2020
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Cholera Vaccine, Live, Oral, in chronological order.
Reference approval
Approval date of the reference Cholera Vaccine, Live, Oral product.
5 yr 6 mo ago
Frequently asked questions
Are there biosimilars approved for Cholera Vaccine, Live, Oral (Vaxchora)?
No 351(k) biosimilars or interchangeable biosimilars referencing Cholera Vaccine, Live, Oral are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.